NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
SSE:600713
Price:
4.86 CNY
1.89%
Market Closed
Updated:
May 3, 2024
NanJing Pharmaceutical Co Ltd
Cash from Financing Activities
|
NanJing Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Comparables:
1099
S
601607
600998
C
600511
000963
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Cash from Financing Activities
¥1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
20%
|
CAGR 10-Years
41%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Financing Activities
-¥6.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Financing Activities
¥231.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Financing Activities
-¥632.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Financing Activities
-¥1.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
See Also
What is NanJing Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
1.7B
CNY
1.7B
CNY
Based on the financial report for Sep 30, 2023, NanJing Pharmaceutical Co Ltd's Cash from Financing Activities amounts to 1.7B CNY.
What is NanJing Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
41%
41%
Over the last year, the Cash from Financing Activities growth was 69%.
You don't have any saved screeners yet
